Abstract
Summary
Next-generation sequencing (NGS), also known as high-throughput sequencing, is the catch-all term used to describe a number of different modern sequencing technologies.
LPI (LP Information)' newest research report, the “DNA Next Generation Sequencing Industry Forecast” looks at past sales and reviews total world DNA Next Generation Sequencing sales in 2022, providing a comprehensive analysis by region and market sector of projected DNA Next Generation Sequencing sales for 2023 through 2029. With DNA Next Generation Sequencing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world DNA Next Generation Sequencing industry.
This Insight Report provides a comprehensive analysis of the global DNA Next Generation Sequencing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on DNA Next Generation Sequencing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global DNA Next Generation Sequencing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for DNA Next Generation Sequencing and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global DNA Next Generation Sequencing.
The global DNA Next Generation Sequencing market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for DNA Next Generation Sequencing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for DNA Next Generation Sequencing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for DNA Next Generation Sequencing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key DNA Next Generation Sequencing players cover Illumina, Roche, Pacific Biosciences, BGI, Thermo Fisher Scientific, Qiagen, PerkinElmer, Agilent Technologies and Bio-Rad, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of DNA Next Generation Sequencing market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Consumables
Instruments
Services
Segmentation by application
Hospitals and Clinics
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Illumina
Roche
Pacific Biosciences
BGI
Thermo Fisher Scientific
Qiagen
PerkinElmer
Agilent Technologies
Bio-Rad
Eurofins Scientific
Natera
LabCorp
Macrogen
Novo Gene
WuXi AppTec
Berry Genomics
Brooks Life Sciences
Personalis
Genotypic Technology
Dna Link
LPI (LP Information)' newest research report, the “DNA Next Generation Sequencing Industry Forecast” looks at past sales and reviews total world DNA Next Generation Sequencing sales in 2022, providing a comprehensive analysis by region and market sector of projected DNA Next Generation Sequencing sales for 2023 through 2029. With DNA Next Generation Sequencing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world DNA Next Generation Sequencing industry.
This Insight Report provides a comprehensive analysis of the global DNA Next Generation Sequencing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on DNA Next Generation Sequencing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global DNA Next Generation Sequencing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for DNA Next Generation Sequencing and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global DNA Next Generation Sequencing.
The global DNA Next Generation Sequencing market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for DNA Next Generation Sequencing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for DNA Next Generation Sequencing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for DNA Next Generation Sequencing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key DNA Next Generation Sequencing players cover Illumina, Roche, Pacific Biosciences, BGI, Thermo Fisher Scientific, Qiagen, PerkinElmer, Agilent Technologies and Bio-Rad, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of DNA Next Generation Sequencing market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Consumables
Instruments
Services
Segmentation by application
Hospitals and Clinics
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Illumina
Roche
Pacific Biosciences
BGI
Thermo Fisher Scientific
Qiagen
PerkinElmer
Agilent Technologies
Bio-Rad
Eurofins Scientific
Natera
LabCorp
Macrogen
Novo Gene
WuXi AppTec
Berry Genomics
Brooks Life Sciences
Personalis
Genotypic Technology
Dna Link
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global DNA Next Generation Sequencing Market Size 2018-2029
2.1.2 DNA Next Generation Sequencing Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 DNA Next Generation Sequencing Segment by Type
2.2.1 Consumables
2.2.2 Instruments
2.2.3 Services
2.3 DNA Next Generation Sequencing Market Size by Type
2.3.1 DNA Next Generation Sequencing Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global DNA Next Generation Sequencing Market Size Market Share by Type (2018-2023)
2.4 DNA Next Generation Sequencing Segment by Application
2.4.1 Hospitals and Clinics
2.4.2 Academic & Research Institutes
2.4.3 Pharmaceutical & Biotechnology Companies
2.4.4 Others
2.5 DNA Next Generation Sequencing Market Size by Application
2.5.1 DNA Next Generation Sequencing Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global DNA Next Generation Sequencing Market Size Market Share by Application (2018-2023)
3 DNA Next Generation Sequencing Market Size by Player
3.1 DNA Next Generation Sequencing Market Size Market Share by Players
3.1.1 Global DNA Next Generation Sequencing Revenue by Players (2018-2023)
3.1.2 Global DNA Next Generation Sequencing Revenue Market Share by Players (2018-2023)
3.2 Global DNA Next Generation Sequencing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 DNA Next Generation Sequencing by Regions
4.1 DNA Next Generation Sequencing Market Size by Regions (2018-2023)
4.2 Americas DNA Next Generation Sequencing Market Size Growth (2018-2023)
4.3 APAC DNA Next Generation Sequencing Market Size Growth (2018-2023)
4.4 Europe DNA Next Generation Sequencing Market Size Growth (2018-2023)
4.5 Middle East & Africa DNA Next Generation Sequencing Market Size Growth (2018-2023)
5 Americas
5.1 Americas DNA Next Generation Sequencing Market Size by Country (2018-2023)
5.2 Americas DNA Next Generation Sequencing Market Size by Type (2018-2023)
5.3 Americas DNA Next Generation Sequencing Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC DNA Next Generation Sequencing Market Size by Region (2018-2023)
6.2 APAC DNA Next Generation Sequencing Market Size by Type (2018-2023)
6.3 APAC DNA Next Generation Sequencing Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe DNA Next Generation Sequencing by Country (2018-2023)
7.2 Europe DNA Next Generation Sequencing Market Size by Type (2018-2023)
7.3 Europe DNA Next Generation Sequencing Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa DNA Next Generation Sequencing by Region (2018-2023)
8.2 Middle East & Africa DNA Next Generation Sequencing Market Size by Type (2018-2023)
8.3 Middle East & Africa DNA Next Generation Sequencing Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global DNA Next Generation Sequencing Market Forecast
10.1 Global DNA Next Generation Sequencing Forecast by Regions (2024-2029)
10.1.1 Global DNA Next Generation Sequencing Forecast by Regions (2024-2029)
10.1.2 Americas DNA Next Generation Sequencing Forecast
10.1.3 APAC DNA Next Generation Sequencing Forecast
10.1.4 Europe DNA Next Generation Sequencing Forecast
10.1.5 Middle East & Africa DNA Next Generation Sequencing Forecast
10.2 Americas DNA Next Generation Sequencing Forecast by Country (2024-2029)
10.2.1 United States DNA Next Generation Sequencing Market Forecast
10.2.2 Canada DNA Next Generation Sequencing Market Forecast
10.2.3 Mexico DNA Next Generation Sequencing Market Forecast
10.2.4 Brazil DNA Next Generation Sequencing Market Forecast
10.3 APAC DNA Next Generation Sequencing Forecast by Region (2024-2029)
10.3.1 China DNA Next Generation Sequencing Market Forecast
10.3.2 Japan DNA Next Generation Sequencing Market Forecast
10.3.3 Korea DNA Next Generation Sequencing Market Forecast
10.3.4 Southeast Asia DNA Next Generation Sequencing Market Forecast
10.3.5 India DNA Next Generation Sequencing Market Forecast
10.3.6 Australia DNA Next Generation Sequencing Market Forecast
10.4 Europe DNA Next Generation Sequencing Forecast by Country (2024-2029)
10.4.1 Germany DNA Next Generation Sequencing Market Forecast
10.4.2 France DNA Next Generation Sequencing Market Forecast
10.4.3 UK DNA Next Generation Sequencing Market Forecast
10.4.4 Italy DNA Next Generation Sequencing Market Forecast
10.4.5 Russia DNA Next Generation Sequencing Market Forecast
10.5 Middle East & Africa DNA Next Generation Sequencing Forecast by Region (2024-2029)
10.5.1 Egypt DNA Next Generation Sequencing Market Forecast
10.5.2 South Africa DNA Next Generation Sequencing Market Forecast
10.5.3 Israel DNA Next Generation Sequencing Market Forecast
10.5.4 Turkey DNA Next Generation Sequencing Market Forecast
10.5.5 GCC Countries DNA Next Generation Sequencing Market Forecast
10.6 Global DNA Next Generation Sequencing Forecast by Type (2024-2029)
10.7 Global DNA Next Generation Sequencing Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 Illumina
11.1.1 Illumina Company Information
11.1.2 Illumina DNA Next Generation Sequencing Product Offered
11.1.3 Illumina DNA Next Generation Sequencing Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Illumina Main Business Overview
11.1.5 Illumina Latest Developments
11.2 Roche
11.2.1 Roche Company Information
11.2.2 Roche DNA Next Generation Sequencing Product Offered
11.2.3 Roche DNA Next Generation Sequencing Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Roche Main Business Overview
11.2.5 Roche Latest Developments
11.3 Pacific Biosciences
11.3.1 Pacific Biosciences Company Information
11.3.2 Pacific Biosciences DNA Next Generation Sequencing Product Offered
11.3.3 Pacific Biosciences DNA Next Generation Sequencing Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Pacific Biosciences Main Business Overview
11.3.5 Pacific Biosciences Latest Developments
11.4 BGI
11.4.1 BGI Company Information
11.4.2 BGI DNA Next Generation Sequencing Product Offered
11.4.3 BGI DNA Next Generation Sequencing Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 BGI Main Business Overview
11.4.5 BGI Latest Developments
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Information
11.5.2 Thermo Fisher Scientific DNA Next Generation Sequencing Product Offered
11.5.3 Thermo Fisher Scientific DNA Next Generation Sequencing Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Thermo Fisher Scientific Main Business Overview
11.5.5 Thermo Fisher Scientific Latest Developments
11.6 Qiagen
11.6.1 Qiagen Company Information
11.6.2 Qiagen DNA Next Generation Sequencing Product Offered
11.6.3 Qiagen DNA Next Generation Sequencing Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Qiagen Main Business Overview
11.6.5 Qiagen Latest Developments
11.7 PerkinElmer
11.7.1 PerkinElmer Company Information
11.7.2 PerkinElmer DNA Next Generation Sequencing Product Offered
11.7.3 PerkinElmer DNA Next Generation Sequencing Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 PerkinElmer Main Business Overview
11.7.5 PerkinElmer Latest Developments
11.8 Agilent Technologies
11.8.1 Agilent Technologies Company Information
11.8.2 Agilent Technologies DNA Next Generation Sequencing Product Offered
11.8.3 Agilent Technologies DNA Next Generation Sequencing Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Agilent Technologies Main Business Overview
11.8.5 Agilent Technologies Latest Developments
11.9 Bio-Rad
11.9.1 Bio-Rad Company Information
11.9.2 Bio-Rad DNA Next Generation Sequencing Product Offered
11.9.3 Bio-Rad DNA Next Generation Sequencing Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Bio-Rad Main Business Overview
11.9.5 Bio-Rad Latest Developments
11.10 Eurofins Scientific
11.10.1 Eurofins Scientific Company Information
11.10.2 Eurofins Scientific DNA Next Generation Sequencing Product Offered
11.10.3 Eurofins Scientific DNA Next Generation Sequencing Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Eurofins Scientific Main Business Overview
11.10.5 Eurofins Scientific Latest Developments
11.11 Natera
11.11.1 Natera Company Information
11.11.2 Natera DNA Next Generation Sequencing Product Offered
11.11.3 Natera DNA Next Generation Sequencing Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Natera Main Business Overview
11.11.5 Natera Latest Developments
11.12 LabCorp
11.12.1 LabCorp Company Information
11.12.2 LabCorp DNA Next Generation Sequencing Product Offered
11.12.3 LabCorp DNA Next Generation Sequencing Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 LabCorp Main Business Overview
11.12.5 LabCorp Latest Developments
11.13 Macrogen
11.13.1 Macrogen Company Information
11.13.2 Macrogen DNA Next Generation Sequencing Product Offered
11.13.3 Macrogen DNA Next Generation Sequencing Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Macrogen Main Business Overview
11.13.5 Macrogen Latest Developments
11.14 Novo Gene
11.14.1 Novo Gene Company Information
11.14.2 Novo Gene DNA Next Generation Sequencing Product Offered
11.14.3 Novo Gene DNA Next Generation Sequencing Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Novo Gene Main Business Overview
11.14.5 Novo Gene Latest Developments
11.15 WuXi AppTec
11.15.1 WuXi AppTec Company Information
11.15.2 WuXi AppTec DNA Next Generation Sequencing Product Offered
11.15.3 WuXi AppTec DNA Next Generation Sequencing Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 WuXi AppTec Main Business Overview
11.15.5 WuXi AppTec Latest Developments
11.16 Berry Genomics
11.16.1 Berry Genomics Company Information
11.16.2 Berry Genomics DNA Next Generation Sequencing Product Offered
11.16.3 Berry Genomics DNA Next Generation Sequencing Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Berry Genomics Main Business Overview
11.16.5 Berry Genomics Latest Developments
11.17 Brooks Life Sciences
11.17.1 Brooks Life Sciences Company Information
11.17.2 Brooks Life Sciences DNA Next Generation Sequencing Product Offered
11.17.3 Brooks Life Sciences DNA Next Generation Sequencing Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 Brooks Life Sciences Main Business Overview
11.17.5 Brooks Life Sciences Latest Developments
11.18 Personalis
11.18.1 Personalis Company Information
11.18.2 Personalis DNA Next Generation Sequencing Product Offered
11.18.3 Personalis DNA Next Generation Sequencing Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 Personalis Main Business Overview
11.18.5 Personalis Latest Developments
11.19 Genotypic Technology
11.19.1 Genotypic Technology Company Information
11.19.2 Genotypic Technology DNA Next Generation Sequencing Product Offered
11.19.3 Genotypic Technology DNA Next Generation Sequencing Revenue, Gross Margin and Market Share (2018-2023)
11.19.4 Genotypic Technology Main Business Overview
11.19.5 Genotypic Technology Latest Developments
11.20 Dna Link
11.20.1 Dna Link Company Information
11.20.2 Dna Link DNA Next Generation Sequencing Product Offered
11.20.3 Dna Link DNA Next Generation Sequencing Revenue, Gross Margin and Market Share (2018-2023)
11.20.4 Dna Link Main Business Overview
11.20.5 Dna Link Latest Developments
12 Research Findings and Conclusion